Lipoprotein component associated with hepatitis C virus is essential for virus infectivity

Current Opinion in Virology

Volumn 1, Issue 1, 2011, Pages 19-26

  Shimizu, Yuko ^a   Hishiki, Takayuki ^a   Ujino, Saneyuki ^a   Sugiyama, Kazuo ^b   Funami, Kenji ^a   Shimotohno, Kunitada ^a  

^a CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; VIRUS PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; LIFE CYCLE; LIPID METABOLISM; MICROENVIRONMENT; NONHUMAN; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION;

EID: 79960455518     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.05.017     Document Type: Article

References (48)

1. World Health Organization: Hepatitis C: global prevalence. Wkly Epidemiol Rec 2000, 75:18-19.
2. Liang TJ, Jeffers LJ, Reddy KR, de Medina M, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993, 18:1326-1333. (Pubitemid 23348417)
3. Yoon EJ, Hu K-Q: Hepatitis C virus infection and hepatic steatosis. Int J Med Sci 2006, 3:53-56.
4. Goodman ZD, Ishak KG: Histopathology of hepatitis C virus infection. Semin Liver Dis 1995, 15:70-91.
5. Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001, 21:3-16. (Pubitemid 32240482)
6. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998, 4:1065-1070.
7. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA et al.: Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteinsof hepatitis C virus. Gastroenterology 2002, 122:352-365. (Pubitemid 34116987)
8. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman M, Miyamura T et al.: Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci US A 1997, 94:1200-1205. (Pubitemid 27087828)
9. Sabile A, Perlemuter G, Bonbo F, Kohara K, Demaugre F, Matsuura Y, Brechot C, Barba G: Hepatitis C virus core protein binds to apolipoprotein A11 and its secretion is modulated by fibrates. Hepatology 1999, 4:1064-1076. (Pubitemid 29458298)
10. Targett-Adams P, Hope G, Boulant S, McLauchlan J: Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. J Biol Chem 2008, 283:16850-16859.
11. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, •• Bartenschlager R, Wakita T, Hijikata M, Shimotohno K: The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007, 9:1089-1097. Increased lipid droplet by HCV infection was shown to be important for virus production. (Pubitemid 47338147)
12. Shavinskaya A, Boulant S, Penin F, McLauchlan J, • Bartenschlager R: The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 2007, 282:37158-37169. Association of HCV core with the lipid droplet requires HCV production.
13. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G et al.: Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002, 16:185-194. (Pubitemid 34113012)
14. Domitrovich AM, Femlee DJ, Siddiqui A: Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem 2005, 280:39802-39808. (Pubitemid 41779113)
15. Partin JS, Partin JC, Schubert WK, McAdams AJ: Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis. Gastroenterology 1974, 67:107-118.
16. Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz MM, Hussain MM et al.: Liver microsomal trigriceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 2006, 130:1661-1669. (Pubitemid 43668848)
17. Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T et al.: Critical role of PA28gannma in hepatitis C virus-associated steatogenesis and hepatocellular carcinoma. Proc Natl Acad Sci USA 2007, 104:1661-1666. (Pubitemid 46214647)
18. Thomssen R, Bonk S, Thiele A: Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins. Med Microbiol Immunol 1993, 182:329-334. (Pubitemid 24011208)
19. André P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Bréchot C, Paranhos-Baccalà G, Lotteau V: Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002, 76:6919-6928. (Pubitemid 41246207)
20. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX: Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999, 96:12766-12771. (Pubitemid 29513577)
21. Molina S, Castet V, Fournier-Wirth C, Pichard-Garcia L, Avner R, Harats D, Roitelman J, Barbaras R, Graber P, Ghersa P et al.: The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 2007, 46:411-419. (Pubitemid 46201721)
22. Thomssen R, Bonk S, Propfe C, Heermann K-H, Köchel HG, Uy A: Association of hepatitis C virus in human sera with β-lipoprotein. Med Microbiol Immunol 1992, 181:293-300.
23. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA et al.: Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626. (Pubitemid 41033648)
24. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M et al.: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11:791-796. (Pubitemid 41021213)
25. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005, 102:9294-9299. (Pubitemid 40923557)
26. Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A, • Date T, Matsuura Y, Miyamura T, Wakita T et al.: Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 2008, 82:7964-7976. Point mutation in the domain 3 of HCV NS5A protein abrogates production of virus particle.
27. Yi M, Ma Y, Yates J, Lemon SM: Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog 2009, 5:e1000403.
28. Jirasko V, Montserret R, Lee JY, Gouttenoire J, Moradpour D, Penin F, Bartenschlager R: Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLoS Pathog 2010, 6:e1001233.
29. Ma Y, Anantpadma M, Timpe JM, Shanmugam S, Singh SM, Lemon SM, Yi M: Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J Virol 2011, 85:1706-1717.
30. Miyanari Y, Hijikata M, Yamaji M, Hosaka M, Takahashi H, Shimotohno K: Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J Biol Chem 2003, 278:50301-50308. (Pubitemid 37548871)
31. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M Jr, Ye J: • Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 2007, 104:5848-5853. Functional association of HCV egress and VLDL has been shown. (Pubitemid 47175622)
32. •]. (Pubitemid 351293514)
33. Icard V, Diaz O, Scholtes C, Cocon P, Ramière L, • Bartenschlager C, Penin R, Lotteau F, André VP: Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLos ONE 2009, 4:e4223. Association of HCV envelope protein and lipoprotein is disclosed.4
34. Jing J, Luo G: Apolipoprotein E but not B is required for the • formation of infectious hepatitis C virus particles. J Virol 2009, 83:12680-12691. Importance of apolipoprotein E rather than apolipoprotein B in infectious HCV production is described.
35. Chang K-S, Jiang J, Cai Z, Luo G: Human apolipoprotein E is •• required for infectivity and production of hepatitis C virus in cell culture. J Virol 2007, 81:13783-13793. Apolipoprotein E plays important role in HCV infectivity. (Pubitemid 350247871)
36. Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, Funami K, •• Ohsaki Y, Fujimoto T, Takaku H, Wakita T et al: Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 2010, 84:12048-12057. HCV infectivity is influenced by apolipoprotein E isoforms.
37. Mancone C, Steindler C, Santangelo L, Simonte G, Vlassi C, Longo MA, D'Offizi G, Di Giacomo C, Pucillo LP, Amicone L et al.: Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut 2011, 60:378-386.
38. Shimizu Y, Hishiki T, Sugiyama K, Ogawa K, Funami K, Kato A, • Ohsaki Y, Fujimoto T, Takaku H, Shimotohno K: Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins. Virology 2010, 407:152-159. Association of HCV with lipoprotein is shown by biochemical analysis.
39. Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, Bienz K, Moradpour D: Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 2003, 77:5487-5492. (Pubitemid 36460961)
40. Benga WJ, Krieger SE, Dimitrova M, Zeisel MB, Parnot M, Lupberger J, Hildt E, Luo G, McLauchlan J, Baumert TF et al.: Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 2010, 51:43-53.
41. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G et al.: Binding of hepatitis C virus to CD81. Science 1998, 282:938-941. (Pubitemid 28507525)
42. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, Scarselli E, Cortese R, Nicosia A, Cosset F-L: Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 2003, 278:41624-41630. (Pubitemid 37310418)
43. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, • Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM: Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007, 446:801-805. Claudin-1 has been shown to be a receptor for HCV. (Pubitemid 46582027)
44. Owen DM, Huang H, Ye J, Gale M Jr: Apolipoprotein E on •• hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 2009, 394:99-108. LDLR is shown to be a receptor for HCV.
45. Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, Toyoda H, K-Toyoda A, Toida T, van Kuppevelt TH, Depla E et al.: Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 2003, 278:41003-41012. (Pubitemid 37280923)
46. Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, Cosset FL, Wakita T, Jaeck D, Doffoel M, Royer C et al.: Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 2007, 46:1722-1731.
47. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitell A: The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002, 21:5017-5025.
48. Li X, Kan HY, Lavrentiadou S, Krieger M, Zannis V: Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI. J Biol Chem 2002, 277:21149-21157.